Trifluoroacetic acid → HCID 59267851, compound

HRID 1809420Notes

Reaction equation

HRID 1809420 reaction equation
C(O)(C(F)(F)F)=O.C(OC(=O)[NH:14][C:15]1[S:16][C:17]([C:20]([CH3:41])([CH3:40])[CH2:21][O:22][Si:23]([C:36]([CH3:39])([CH3:38])[CH3:37])([C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)=[N:18][N:19]=1)(C)(C)C>C(Cl)Cl>[C:36]([Si:23]([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)([C:30]1[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1)[O:22][CH2:21][C:20]([C:17]1[S:16][C:15]([NH2:14])=[N:19][N:18]=1)([CH3:41])[CH3:40])([CH3:37])([CH3:38])[CH3:39]

Participants

4

Procedure

A 10% solution of TFA in DCM (720 mL) is added at 0° C. to a solution of {5-[2-(tert-Butyl-diphenyl-silanyloxy)-1,1-dimethyl-ethyl]-1,3,4-thiadiazol-2-yl}-carbamic acid tert-butyl ester (12.0 g, 23.4 mmol) in DCM (800 mL). The reaction mixture is stirred at room temperature for 14 h. The solvent is removed under reduced pressure and the crude purified by column chromatography to afford 8.8 g of 5-[2-(tert-butyl-diphenyl-silanyloxy)-1,1-dimethyl-ethyl]-1,3,4-thiadiazol-2-ylamine as a viscous liquid. Yield: 91%; 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.05 (9H, s), 1.30 (6H, s), 3.60 (2H, s), 7.30-7.50 (6H, m), 7.50-7.70 (4H, m), 9.00 (2H, s); m/z 412 [M+H].

Workup

  1. customThe solvent is removed under reduced pressure
  2. customthe crude purified by column chromatography

Sources & evidence

ORD record
ord-0b7d98a1b18f48d8b876bca73aa5238b
Source dataset
uspto-grants-2013_01
Patent number
US08362039B2

Reaction notes

Loading…